These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39112288)

  • 1. Lack of efficacy of oral N-acetylcysteine ​​in the treatment of facial melasma in women: a randomized, double-blind, placebo-controlled clinical trial.
    Alfredo MAC; Holanda IRM; Cassiano DP; Espósito ACC; Lima PB; Miot HA
    An Bras Dermatol; 2024; 99(6):928-931. PubMed ID: 39112288
    [No Abstract]   [Full Text] [Related]  

  • 2. French maritime pine bark extract (pycnogenol) in association with triple combination cream for the treatment of facial melasma in women: a double-blind, randomized, placebo-controlled trial.
    Lima PB; Dias JAF; Esposito ACC; Miot LDB; Miot HA
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):502-508. PubMed ID: 32841433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of oral 5 mg melatonin in the treatment of facial melasma in women: A double-blind, randomized, placebo-controlled clinical trial.
    Holanda IRM; de Almeida Corrêa Alfredo M; Cassiano DP; Esposito ACC; Lima PB; Bagatin E; Miot HA
    J Eur Acad Dermatol Venereol; 2024 Jul; 38(7):e607-e609. PubMed ID: 38226560
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and Safety of Nicotinamide 10%, Associated with Magnesium Ascorbyl Phosphate 5% and Hyaluronic Acid 5%, Compared to Hydroquinone 4% in Women with Facial Melasma: A Randomized, Double-Blind, Controlled Clinical Trial.
    Barbosa M; de Amorim RP; Cassiano D; Dias M; de Abreu AF; Bagatin E; Miot HA; Espósito ACC
    Clin Cosmet Investig Dermatol; 2024; 17():2215-2223. PubMed ID: 39376788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women.
    Handog EB; Galang DA; de Leon-Godinez MA; Chan GP
    Int J Dermatol; 2009 Aug; 48(8):896-901. PubMed ID: 19659873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amber photobiomodulation versus tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial.
    Galache TR; Galache M; Sena MM; Pavani C
    BMJ Open; 2023 Jul; 13(7):e073568. PubMed ID: 37479524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral ketotifen associated with oral tranexamic acid for the treatment of facial melasma in women: A randomized, double-blind, placebo-controlled trial.
    Cruz ACL; Cassiano DP; Bleixuvehl de Brito M; Espósito ACC; Hassun K; Miot HA; Bagatin E
    J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38702979
    [No Abstract]   [Full Text] [Related]  

  • 8. A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma.
    Lyons A; Stoll J; Moy R
    J Drugs Dermatol; 2018 Sep; 17(9):970-973. PubMed ID: 30235384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
    Kuster Kaminski Arida D; Orso Rebellato PR; Marioto de Campos GL; Costa A; Vilaverde Schmitt J; Larocca Skare T; Rodrigues Lisboa Faucz L
    J Cosmet Dermatol; 2021 Dec; 20(12):4005-4010. PubMed ID: 34077619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential therapy with topical clobetasol for 14 days followed by hydroquinone versus hydroquinone alone in facial melasma treatment: a randomized, double-blind, controlled clinical trial.
    de Amorim RP; Barbosa MMC; Cassiano DP; Esposito ACC; Dias MO; de Abreu AFT; Bagatin E; Miot HA
    Int J Dermatol; 2024 Sep; 63(9):1221-1226. PubMed ID: 38411257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial.
    Mansouri P; Farshi S; Hashemi Z; Kasraee B
    Br J Dermatol; 2015 Jul; 173(1):209-17. PubMed ID: 25251767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ketotifen associated with famotidine for the treatment of facial melasma: a randomized, double-blind, placebo-controlled trial.
    Dias JAF; Lima PB; Cassiano DP; Espósito ACC; Bagatin E; Miot LDB; Miot HA
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):e123-e125. PubMed ID: 34553413
    [No Abstract]   [Full Text] [Related]  

  • 14. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol.
    Maier A; Dharan A; Oliver G; Berk M; Redston S; Back SE; Kalivas P; Ng C; Kanaan RA
    BMC Psychiatry; 2020 Aug; 20(1):397. PubMed ID: 32762663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The formulation and efficacy of topical
    Javedan K; Hydarpur F; Mohammadi Pour P; Najafi F; Mirzaeei S; Rahimi R; Gravandi MM; Farzaei MH
    J Complement Integr Med; 2022 Sep; 19(3):743-751. PubMed ID: 33964194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin cream in chinese patients with melasma: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.
    Gong Z; Lai W; Zhao G; Wang X; Zheng M; Li L; Yang Q; Dang Y; Liu L; Zou Y
    Clin Drug Investig; 2015 Jun; 35(6):385-95. PubMed ID: 25989732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of oral tranexamic acid in the treatment of melasma.
    Colferai MMT; Miquelin GM; Steiner D
    J Cosmet Dermatol; 2019 Oct; 18(5):1495-1501. PubMed ID: 30536592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
    Farshi S; Mansouri P; Kasraee B
    J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, Placebo-controlled Trial to Evaluate the Effectiveness of
    Goh CL; Chuah SY; Tien S; Thng G; Vitale MA; Delgado-Rubin A
    J Clin Aesthet Dermatol; 2018 Mar; 11(3):14-19. PubMed ID: 29606995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.